Introduction {#S2}
============

A substantial fraction of the eukaryotic genome is comprised of transposable elements (TEs). In the human genome, more than half of the euchromatic sequence can be attributed to TEs. Despite their profusion, TEs have historically been regarded as *selfish* genomic parasites or *junk DNA* that have little to no contribution in the functioning of the human genome \[[@R1],[@R2]\]. The aforementioned studies argued that TEs can maintain and proliferate in the host genome solely because of their ability to out-compete the host genome in terms of their replication ability, and are therefore not constrained to have a functional contribution necessary for selection. These studies shaped the paradigm for research in the field by discouraging the search for the functional relevance of TE sequences in the human genome.

Over the last several years, scientists discovered gene features such as promoters, UTR's and exons derived from TE insertions that regulate transcription \[[@R3],[@R4]\]. Exonization is a process whereby genes acquire new exons from non-protein-coding DNA sequences, often times TEs due to the presence of internal splice site-like structures within their sequences \[[@R5]\]. A classic example is the *agouti* locus in mice, where its expression results in a yellow coat color, obesity, diabetes, and tumor susceptibility \[[@R6]\]. The transcription of the *agouti* gene is influenced by a cryptic promoter originating from an intracisternal particle (IAP) element, a member of the LTR-Retrotransposon family, which generates a transcript that reads through the *agouti* gene. The number of transcripts originating from the IAP element depends on its methylation state where a de-methylated IAP element is capable of generating transcripts resulting in an increase in the expression of the *agouti* gene.

Indeed there are several instances where TEs have been implicated in functionally contributing to the human genome \[[@R7]\]. These contributions include TEs providing regulatory and coding sequences such as transcription factor binding sites, promoters, exons, and enhancers \[[@R8]--[@R12]\]. As is the case with the Agouti locus described above, TE derived gene features are often epigenetically regulated to cater to the functional needs of the cell type they are in. We have recently shown that TEs donate several hundred canonical promoters and transcription start sites to the human genome that are epigenetically modified in such a way as to facilitate cell type specific expression \[[@R13],[@R14]\]. Similarly, we have also demonstrated that TEs donate thousands of unique enhancers that are modified by epigenetic histone modifications and are functionally relevant in driving cell type specific gene expression \[[@R14],[@R15]\].

These studied provided the motivation to explore the global contribution of TE derived gene features in various human cell types and their potential role in gene regulation. The availability of RNA-sequencing (RNA-Seq) and epigenetic data from various human cell lines in the Encyclopedia of DNA Elements (ENCODE) project provides an unprecedented survey of the landscape of transcription genome-wide and, in a limited way, catalogues transcripts initiated from repetitive elements in a cell line specific manner \[[@R16]\]. However, there is a paucity of information regarding epigenetic regulation of TE-derived transcripts. To that end, we used the RNA-seq data as well as the epigenetic data provided by the ENCODE project in two human hematopoietic cell lines (GM12878 and K562)in order to ascertain the interplay between the exonization of TEs into coding sequences and epigenetic regulation of transcription on a genome-wide scale. GM12878 is a lymphoblastoid cell line derived from a female donor of northern and western European descent whereas K562 is a cancer cell line from a female patient suffering from Chronic Myelogenous Leukemia (CML). In each cell line, we found several thousand instances of TEs donating coding sequences to human genes and that TE exonization is significantly greater in the reference guided transcriptome assembly (Refseq \[[@R17]\] and Gencode \[[@R18]\]) than an assembly without the aid of a reference transcriptome. In addition, integration of histone modifications chromatin immunoprecipitation sequencing (ChIP-Seq) data, cap analysis of gene expression (CAGE) data and DNAseI hypersensitivity site (DHS) data allowed us to postulate that TEs contribute a substantial fraction of human coding sequences that are epigenetically regulated in accordance with the gene expression in the two cell types.

Materials and Methods {#S3}
=====================

Datasets {#S4}
--------

RNA-seq data from GM12878 and K562 cell lines generated by Caltech were downloaded from the University of California Santa Cruz (UCSC) genome browser's ENCODE downloads section and is also available in the NCBI GEO repository under accession \#GSE23316. In each cell line, two replicate libraries of (75bpx2) paired-end reads were used for the analysis.

ChIP-seq data in GM12878 and K562 cell lines for four histone modifications (H3K4me3, H3K9ac, H3K27ac, H3K36me3) commonly found at transcription start sites and exons, were obtained as aligned tag files generated by the Broad institute and downloaded from the ENCODE section of the UCSC genome browser \[[@R19],[@R20]\]. The data is also available in the NCBI GEO repository under accession \#GSE29611.

Open chromatin data generated by Duke University under the ENCODE project using DHS mapping were also obtained as 'Peaks' file from the UCSC genome browser and is also available in the NCBI GEO repository under accession \#GSE32970.

CAGE data generated by the RIKEN group for ENCODE cell lines, were also obtained from the UCSC genome browser as "CAGE Clusters" of loci deemed significantly enriched for CAGE tags against a background tag distribution. The raw data is also available in the NCBI GEO repository under accession \#GSE34448.

The aforementioned datasets were co-located with transposable element (TE) annotation using custom Perl scripts as described by Repeat Masker version 3.2.7. The criteria for delineating TE derived RNA-seq exons were taken as any overlap between an exon and a TE with respect to genomic coordinates. Similarly, all other datasets (Histone modifications, DHS, CAGE) were co-located using genomic overlap between the TE annotation and the respective tag/peak/cluster densities.

RNA-seq analysis {#S5}
----------------

Raw paired-end sequence reads of length 75bpx2 with an insert size of 200bp were mapped individually to the reference human genome (hg19) using *Bowtie* (version 0.12.7) allowing at most 2 mismatches and multiple alignments for a read pair \[[@R21]\]. The *TopHat* (Cahnge oveer all in article) program was used with default parameters to ascertain splice junctions in the mapped reads \[[@R22]\]. *Cufflinks* (version 1.0.3) was used to assemble transcripts and estimate their abundance given a reference transcriptome specified by the Refseq and Gencode (version 7) gene models \[[@R18], [@R23],[@R24]\]. As shown in (Figure S1), we used *Bowtie* to map the RNA-Seq reads to the hg19 genome, and then used *TopHat* to detect splice junctions and *Cufflinks* to assemble the transcriptome using two different techniques in order to determine the extent of TEs incorporation. First we built the transcriptome using reference annotations from Refseq \[[@R17]\] and Gencode \[[@R18]\] to 'guide' the assembly of RNA-seq reads. We also built the transcriptome without the aid of a reference gene model to yield a 'transcript-reference-free' characterization of RNA-seq reads. We co-located TE-annotations with RNA-seq data resulting from each assembly process and discovered that the fraction of TE-derived transcripts and exons is several folds higher in non-reference guided assembly. We further evaluated these data for functional signatures such as epigenetic histone modifications present at promoters and exons, cap analysis of gene expression (CAGE) data which identifies transcript start sites (TSS), and DNAseI hypersensitive sites (DHSs) which locate actively transcribing regions as characterized by open chromatin.

Statistical analyses {#S6}
--------------------

A Student's t-test-was used to compare gene expression transcripts from the non-reference guided assembly between GM12878 and K562 cell lines. False discovery rate (FDR) adjusted p-values (q-values) were used to control for multiple testing and to determine significance at q-value\<0. 05. Gene Ontology and functional enrichment of differentially expressed genes were performed using the DAVID Bioinformatics Resources v6. 7 \[[@R25],[@R26]\]. Pearson's correlation (r) was also used to ascertain the relationship between various trends. The significance of a trend was determined by approximating the sampling distribution of *r* to the Student's t-distribution using the formula: $$t = r\sqrt{\frac{n - 2}{1 - r^{2}}}$$

Results and Discussion {#S7}
======================

TE-derived human gene transcripts {#S8}
---------------------------------

We obtained RNA-seq data generated by Caltech for the ENCODE project in GM12878 and K562 cell lines. These data were processed using the *Bowtie/TopHat/Cufflinks* pipeline as described in the Materials and Methods section. The reads were first mapped to the reference human genome (hg19) using *Bowtie* and the *TopHat* program was used to map splice junctions \[[@R21],[@R22]\]. The third and final step in this pipeline is quantification by *Cufflinks* which assembles the transcripts and estimates their abundance \[[@R23],[@R24],[@R27]\]. Normalized transcript abundance is used as a measure of expression of the respective genes. The assembly and annotation of RNA-seq transcripts by *Cufflinks* can be aided by providing a reference transcriptome such as Refseq to assign the mapped reads and splice junctions to known transcripts. This process generally results in a higher number of transcripts discovered but is biased towards the transcripts that exist in the reference annotation. *Cufflinks* can also build the transcriptome without the use of reference annotation which can be used to detect a greater number of novel transcripts that do not exist in gene model databases.

We ran Cufflinks in three different ways: without the aid of a reference transcriptome, using Refseq as reference annotation, and using Gencode as reference. This process resulted in vastly different results as illustrated in [Figure 1](#F1){ref-type="fig"} and [Figure 2](#F2){ref-type="fig"}. In both cell lines, the use of a reference transcriptome during transcript assembly by Cufflinks resulted in the discovery of a considerably larger number of transcripts and exons. Transcriptome assembly using Refseq yielded the highest number of transcripts and exons, with (GM12878:1.87M and K562:1.92M) exons, and (GM12878:326K and K562:330K) transcripts. This was followed by a Gencode guided assembly which detected (GM12878:1.11M and K562:1.11M) exons and (GM12878:195K and K562:195K) transcripts in the two cell lines. On the other hand, non-reference guided assembly was able to discover only (GM12878:325K and K562:305K) exons and (GM12878:70K and K562:60K) transcripts in the two cell lines. Compared to non-reference guided assembly, these figures represent approximately 3X and 6X increase in the number of transcripts and exons discovered by Gencode and Refseq guided assembly, respectively ([Figure 3](#F3){ref-type="fig"} and [Table 1](#T1){ref-type="table"}).

To ascertain the contribution of transposable elements to human gene coding sequences, we co-located the transcripts and exons from each of the three assemblies with TE annotation as provided by Repeat Masker \[[@R28]\]. The term exonization in the context of TEs is described as the process by which a TE sequence is adapted to serve as an exon by the host genome. A transcript or exon is considered 'TE-derived' if any part of its coding sequence overlaps with TE annotation. The fraction of TE-derived coding sequences varies widely between the three transcriptome assemblies. As such, the non-guided assembly yields the highest proportion of TE-derived genes compared to Gencode and Refseq guided assemblies ([Figure 3](#F3){ref-type="fig"}). These results indicate that TE-derived human gene coding sequences are vastly under-represented in the reference transcriptome annotations.

Having recognized the substantial under-representation in the fraction of TE-derived exons, we sought to determine the number of these coding sequences that are common between the reference and non-reference guided assemblies. To that end, we found all transcripts or exons from different builds that have common start and end positions in the genome. In order to compensate for possible imprecision in the prediction of transcripts and exon coordinates, we allowed a 10bp wiggle room in the comparison of start and end sites of transcripts and exons from different transcriptome assemblies. We found that a very small number of TE-derived transcripts and exons are in fact common between the reference and non-reference guided assemblies ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Since the total number of transcripts and exons discovered by the non-reference guided assembly is considerably smaller than that of reference guided assembly, it follows that a proportionally small number of TE-derived exons are in fact represented in this dataset. In other words, the total number of TEs-derived exons detected by the non-reference guided assembly may only represent a small percentage of the actual number of TEs involved presumably in serving the coding needs of the human genome. As such, these results offer an unbiased estimate of the percentage of human coding sequences derived from TEs and indicate that the contribution in absolute terms may be significantly higher. Thus, these results reveal a significantly higher level of TE contribution to human exons than previously thought.

TE-derived first exons {#S9}
----------------------

We evaluated the contribution of TEs in donating various gene segments including TSS (transcription start site) and first exons and compared it to subsequent exons. We report here that TEs are significantly over-represented in donating TSS and first exons as opposed to later exons ([Figure 4](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). In the GM 12878 cell line (36,464/325,351) or 11.2% of all exons are derived from TEs, whereas (30,778/70,669) or 43.5% of first exons appear to be derived from TEs. Similarly, in the K562 cell line (30,126/305,792) or 9.9% of all exons are donated by TEs while (23,951/60,895) or 39.3% of first exons are TE-derived. Furthermore, we found 1291 transcripts (supplemental Table S1) mapped to 69 genes ([Table 3](#T3){ref-type="table"}) which are differentially expressed (q-value\<0.05) between the GM12878 and K562 cell lines and have TEs inserted into the first exon of the genes. These genes primarily have molecular functions in the immunoglobulin receptor family class and enrich for the Gene Ontology immune response biological process (FDR\<0.1). These data seem to support the model illustrated by the *agouti* gene in mouse where an IAP element (LTR Retrotransposon) residing upstream of the *agouti* locus generates a transcript that reads through the *agouti* gene \[[@R29]\]. In the process, the IAP element donates a transcription start site and is primed to serve as the first exon for the *agouti* gene. Our data suggest that this model is a common route through which TEs donate an alternative TSS and the first exon that can affect the transcription of nearby genes.

Age and relative contribution of TE families {#S10}
--------------------------------------------

All major families of TEs are represented in contributing transcripts in the two cell types studied. We evaluated the relative contribution of various TE families in donating coding sequences in the RNA-seq transcripts by normalizing the number of transcripts attributed to a TE family with the background genomic abundance of the family. Different families of TEs have significantly (χ^2^ test p-value\<0. 001) different contributions in providing coding sequences as illustrated in [Figure 5](#F5){ref-type="fig"}.

We determined the relative age of each TE family by using their average divergence (millidiv) from a consensus ancestral sequence. Using this approach, we classified the TE families in the following order according to age, from youngest to the oldest: Alu, L1, LTR-Retrotransposons, DNA-transposons, L2 and MIR. We observed that the relative contribution of each TE family increases with increasing age of the family with the exception of Alu elements. Intuitively, older TE families have had a longer period of time for individual elements to be adopted by the genome and thus have relatively higher contribution compared to the younger families. Our observations are consistent with this phenomenon as older TE families are significantly more enriched in gene features. On the other hand, the youngest family of TEs i.e., Alu elements do not follow this paradigm and are highly enriched in donating coding sequences. It has previously been shown that Alu elements are enriched in gene rich regions which can be attributed to their over-representation in donating coding sequences \[[@R30]\].

Epigenetic regulation of TE-derived genes {#S11}
-----------------------------------------

To strengthen the functional relevance of TE-derived exons, we evaluated the various epigenetic markers that are known to mark active exons. To that end, we downloaded histone modification data for four histone modifications (H3K4me3, H3K9ac, H3K27ac, and H3K36me3), DHS data as well as CAGE data. These four histone modifications have been shown to mark actively transcribing TSSs and exons \[[@R31]--[@R33]\]. Similarly, CAGE data is an established technique to determine the TSSs for actively transcribing genes \[[@R34]\]. Finally, DHSs are used to identify open chromatin and are shown to be correlated with activation of gene expression \[[@R35],[@R36]\].

These data were mapped to the TE-derived exons using their genomic loci. We divided the TE-derived exons into 100 bins according to their expression in the two cell lines and plotted their average epigenetic modification against their expression ([Figures 6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}). In both cell lines, the expression of TE-derived exons is strongly positively correlated with the histone modifications, DHSs, and CAGE clusters. These epigenetic indicators of gene expression demonstrate the functional significance of TE-derived exons in presumably regulating gene expression in their respective cell types. Our data further suggests that transposable elements that donate coding sequences to human genes have been epigenetically modified in such a way as to facilitate their role in driving gene expression.

Conclusions {#S12}
===========

Our data suggests that TEs have a substantial contribution in donating coding sequences to human genes. The level of contribution is made apparent by transcriptome assembly without the aid of a reference transcriptome and far exceeds that provided by the reference transcriptome. TE-derived exons and transcripts are also epigenetically regulated in such a way as to potentially facilitate the establishment of cell type specific gene expression. Our results in no way discounts or diminishes the presumed importance of TEs in non-coding regions but we make an association between exonization of TEs and epigenetic regulation of transcription. Furthermore, our interpretation of the results mainly centered on the findings from the reference guided assembly of the transcripts sequence reads as we could leverage the gene model as annotation for associating with the epigenetic data. Thus, one can ascertain that there are potentially novel transcripts from the non-reference guided assembly that are presumably as important as the epigenetically regulated ones we detected. Further investigation into these potential transcript regulators is of interest and we are also considering computational ways to discern false positive and false negative detection of TE exonization using synthetic reads and/or spike-ins in the absence of the ground truth.
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![Comparison of Gencode guided versus non-reference guided assembly of transcripts and exons.The larger circles represent all transcripts and exons whereas the smaller circles represent TE-derived transcripts and exons (a) GM12878 exons (b) GM12878 transcripts (c) K562 exons (d) K562 transcripts.](nihms524458f1){#F1}

![Comparison of Refseq guided *vs* non-reference guided assembly of transcripts and exons.The larger circles represent all transcripts and exons whereas the smaller circles represent TE-derived transcripts and exons (a) GM12878 exons (b) GM12878 transcripts (c) K562 exons (d) K562 transcripts.](nihms524458f2){#F2}

![TE-derived (a) transcripts and (b) exons Illustrated as a fraction of total.](nihms524458f3){#F3}

![Fraction of TE-derived exons in all exons *vs* first exons. TE-derived exons form a signifcantly higher proportion of first exons compared to all exons (a) larger circle represents all exons while the smaller circle represents first exons and (b) TE-derived exons expressed as a percentage of total exons.](nihms524458f4){#F4}

![Relative contribution of TE-families in donating coding sequence to human gene transcripts. Absolute counts normalized by genomic background abundance for each family.](nihms524458f5){#F5}

![FPKM values for all TE-derived exons were sorted and binned in 100 equal sized bins and plotted against DHS clusters, CAGE clusters, and various histone modifications that mark promoters, TSS and exons in the GM12878 cell line.](nihms524458f6){#F6}

![FPKM values for all TE-derived exons were sorted and binned in 100 equal sized bins and plotted against DHS clusters, CAGE clusters, and various histone modifications that mark promoters, TSS and exons in the K562 cell line.](nihms524458f7){#F7}

###### 

Percentage of TE-derived transcripts and exons as a function of total transcripts and exons in GM12878 and K562 cell lines, refer to [Figure 3](#F3){ref-type="fig"}.

                  Transcripts   Exons          
  --------------- ------------- ------- ------ -----
  Refseq          19.6          13.4    4.2    3.7
  Gencode         12.1          12.1    4.6    4.7
  Non-reference   43.5          39.3    11.2   9.8

###### 

Percentage of TE-derived first exons as a fraction of all exons in GM12878 and K562 cell lines, refer to [Figure 4](#F4){ref-type="fig"}.

                                All exons   First exons
  ---------------- ------------ ----------- -------------
  GM12878          TE derived   11.2        43.5
  Non TE derived   88.8         56.5        
  K562             TE derived   9.9         39.3
  Non TE derived   90.1         60.7        

###### 

Significantly differentially expressed genes (q-value\<0.05) between GM12878 and K562 cell lines and have TE inserted into the first exon of the genes.

  -------------------------------------------------------------------------------------------------------------------------------------------------
  Representative transcript   Uni Gene Cluster   Gene name                                                                            Gene symbol
  --------------------------- ------------------ ------------------------------------------------------------------------------------ -------------
  NM_003975                   Hs.103527          SH2 domain containing 2A                                                             SH2D2A

  NM_001039477                Hs.10649           Chromosome 1 open reading frame 38                                                   C1orf38

  NM_001146310                Hs.107101          Chromosome 1 open reading frame 86                                                   C1orf86

  NM_019089                   Hs.118727          Hairy and enhancer of split 2 (Drosophila)                                           HES2

  NM_018420                   Hs.125482          Solute carrier family 22, member 15                                                  SLC22A15

  NM_033312                   Hs.127411          CDC14 cell division cycle 14 homolog A (S. cerevisiae)                               CDC14A

  NM_001765                   Hs.132448          CD1c molecule                                                                        CD1C

  NM_016074                   Hs.13880           BolA homolog 1 (E. coli)                                                             BOLA1

  NM_001080471                Hs.142003          Platelet endothelial aggregation receptor 1                                          PEAR1

  NM_001042747                Hs.1422            Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog                        FGR

  NM_001766                   Hs.1799            CD1d molecule                                                                        CD1D

  NM_004672                   Hs.194694          Mitogen-activated protein kinase kinasekinase 6                                      MAP3K6

  NM_148902                   Hs.212680          Tumor necrosis factor receptor superfamily, member 18                                TNFRSF18

  NM_030812                   Hs.2149            Actin-like 8                                                                         ACTL8

  NM_003528                   Hs.2178            Histone cluster 2, H2be                                                              HIST2H2BE

  NM_001166294                Hs.22587           Synovial sarcoma, X breakpoint 2 interacting protein                                 SSX2IP

  NM_014215                   Hs.248138          Insulin receptor-related receptor                                                    INSRR

  NM_173452                   Hs.333383          Ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen)                   FCN3

  NM_006824                   Hs.346868          EBNA1 binding protein 2                                                              EBNA1BP2

  NM_001007794                Hs.363572          Choline/ethanolamine phosphotransferase 1                                            CEPT1

  NM_147192                   Hs.375623          Diencephalon/mesencephalon homeobox 1                                                DMBX1

  NM_002529                   Hs.406293          Neurotrophic tyrosine kinase, receptor, type 1                                       NTRK1

  NM_003517                   Hs.408067          Histone cluster 2, H2ac                                                              HIST2H2AC

  NM_001193300                Hs.408846          Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short\        SEMA4A
                                                 cytoplasmic domain, (semaphorin) 4A                                                  

  NM_052941                   Hs.409925          Guanylate binding protein 4                                                          GBP4

  NM_015696                   Hs.43728           Glutathione peroxidase 7                                                             GPX7

  NM_001143778                Hs.437379          ArfGAP with SH3 domain, ankyrin repeat and PH domain 3                               ASAP3

  NM_030764                   Hs.437393          Fc receptor-like 2                                                                   FCRL2

  NM_001033082                Hs.437922          V-mycmyelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian)       MYCL1

  NM_198715                   Hs.445000          Prostaglandin E receptor 3 (subtype EP3)                                             PTGER3

  NM_003196                   Hs.446354          Transcription elongation factor A (SII), 3                                           TCEA3

  NM_005101                   Hs.458485          ISG15 ubiquitin-like modifer                                                         ISG15

  NM_001195740                Hs.462033          Chromosome 1 open reading frame 93                                                   C1orf93

  NM_001040195                Hs.464438          Angiotensin II receptor-associated protein                                           AGTRAP

  NM_001048195                Hs.469723          Regulator of chromosome condensation 1                                               RCC1

  NM_024772                   Hs.471243          Zinc finger, MYM-type 1                                                              ZMYM1

  NM_002959                   Hs.485195          Sortilin 1                                                                           SORT1

  NM_001199772                Hs.485246          Proteasome (prosome, macropain) subunit, alpha type, 5                               PSMA5

  NM_178454                   Hs.485606          DNA-damage regulated autophagy modulator 2                                           DRAM2

  NM_002744                   Hs.496255          Protein kinase C, zeta                                                               PRKCZ

  NM_001143989                Hs.511849          Neuroblastoma breakpoint family, member 4                                            NBPF4

  NM_003820                   Hs.512898          Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)   TNFRSF14

  NM_004000                   Hs.514840          Chitinase 3-like 2                                                                   CHI3L2

  NM_025008                   Hs.516243          ADAMTS-like 4                                                                        ADAMTSL4

  NM_001178062                Hs.516316          Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin)\        SEMA6C
                                                 6C                                                                                   

  NM_021181                   Hs.517265          SLAM family member 7                                                                 SLAMF7

  NM_022873                   Hs.523847          Interferon, alpha-inducible protein 6                                                IFI6

  NM_152493                   Hs.524248          Zinc finger protein 362                                                              ZNF362

  NM_000760                   Hs.524517          Colony stimulating factor 3 receptor (granulocyte)                                   CSF3R

  NM_001135585                Hs.530003          Solute carrier family 2 (facilitated glucose/fructose transporter), member 5         SLC2A5

  NM_033504                   Hs.534521          Transmembrane protein 54                                                             TMEM54

  NM_024901                   Hs.557850          DENN/MADD domain containing 2D                                                       DENND2D

  NM_005529                   Hs.562227          Heparansulfate proteoglycan 2                                                        HSPG2

  NM_001408                   Hs.57652           Cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila)        CELSR2

  NM_033467                   Hs.591453          Membrane metallo-endopeptidase-like 1                                                MMEL1

  NM_024980                   Hs.632367          G protein-coupled receptor 157                                                       GPR157

  NM_002143                   Hs.632391          Hippocalcin                                                                          HPCA

  NM_014787                   Hs.647643          DnaJ (Hsp40) homolog, subfamily C, member 6                                          DNAJC6

  NM_052938                   Hs.656112          Fc receptor-like 1                                                                   FCRL1

  NM_152890                   Hs.659516          Collagen, type XXIV, alpha 1                                                         COL24A1

  NM_175065                   Hs.664173          Histone cluster 2, H2ab                                                              HIST2H2AB

  NM_207397                   Hs.664836          CD164 sialomucin-like 2                                                              CD164L2

  NM_001114748                Hs.668654          Chromosome 1 open reading frame 70                                                   C1orf70

  NM_144701                   Hs.677426          Interleukin 23 receptor                                                              IL23R

  NM_001013693                Hs.710255          Low density lipoprotein receptor class A domain containing 2                         LDLRAD2

  NM_001037675                Hs.714127          Neuroblastoma breakpoint family, member 1                                            NBPF1

  NM_152498                   Hs.729552          WD repeat domain 65                                                                  WDR65

  NM_001127714                Hs.729693          Human immunodeficiency virus type I enhancer binding protein 3                       HIVEP3

  NM_001164722                Hs.77542           Platelet-activating factor receptor                                                  PTAFR
  -------------------------------------------------------------------------------------------------------------------------------------------------
